Prevalence of Mast Cell Activation Syndrome in Patients With Ehlers Danlos Hypermobile Syndrome With Digestive Disorders

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The aim of the study is to confirm the association between hypermobile Ehlers Danlos syndrome (hEDS) and mast cell activation syndrome (MCAS) in patients with digestive disorders managed in allergology departments.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 14
Healthy Volunteers: f
View:

• with hypermobile Ehlers Danlos syndrome

• with digestive disorders

• 14 years of age or older (minimum age for the MOS-SF 36 questionnaire)

• able to answer the questionnaires

• whose participation in a day hospital at Saint Vincent de Paul dedicated to the assessment of functional digestive pain is planned

• who do not object to the use of their health data for research purposes

⁃ Additional criteria for minors :

⁃ \- No objection to the use of health data for research purposes by parents/guardians

Locations
Other Locations
France
Saint-Vincent-de-Paul hospital
RECRUITING
Lille
Contact Information
Primary
Marie DE SOLERE
drci@ghicl.net
+33320225269
Backup
William's VAN DEN BERGHE, CRA
VanDenBerghe.Williams@ghicl.net
+33320225731
Time Frame
Start Date: 2022-09-28
Estimated Completion Date: 2026-03
Participants
Target number of participants: 30
Sponsors
Leads: Lille Catholic University

This content was sourced from clinicaltrials.gov